Access cutting-edge tuberous sclerosis complex treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access tuberous sclerosis complex specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related tuberous sclerosis complex treatment provided free
This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in TSC infants. This study is supported by research funding from the Office of Orphan Products Division (OOPD) of the US Food and Drug Administration (FDA).
Sponsor: Darcy Krueger
Check if you qualify for this tuberous sclerosis complex clinical trial in Chicago, IL
If you're searching for tuberous sclerosis complex treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced tuberous sclerosis complex specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.